1LEE J H, JUN J B, JUNG S, etal. Higher prevalence of peripheral arthritis among ankylosing spondylitis patients[J]. J Korean Med Sci,2002,17(5):669-673.
2ROUF J, STUCKI G. Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review[J]. J Rheumatology, 1999,26 : 966-970.
3LUKAS C, LANDEWE R, SIEPER J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis[J]. Ann Rheum Dis, 2009,68(1): 18-24.
4WANG F, YAN C G, XIANG H Y, et al. The significance of platelet activation in ankylosing spondylitis[J].Clin Rheumatol, 2008,27 : 767-769.
5GRAN J T, HUSBY G. Ankylosing spondylitis in women[J]. Seminars Arthritis Rheum, 1991,19 (5) : 303-312.
6LEE W, REVEILLE J D, WEISMAN M H, et al. Women with ankylosing spondylitis: a review[J]. Arthritis Rheum, 2008, 59 (3) :449-454.
7JAAKKOLA E, HERZBERG I, LAIHO K, et al. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozy gosity in ankylosing spondylitis[J]. Ann Rheum Dis, 2006, 65: 775-780.
8ΦSTENSEN M, FORGER F, NELSON J L, etal. Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum[J]. Ann Rheum Dis, 2005,64(6) : 839-844.
